US Stock MarketDetailed Quotes

BLPH Bellerophon Therapeutics

Watchlist
  • 0.057
  • 0.0000.00%
Close Mar 28 16:00 ET
695.00KMarket Cap-63P/E (TTM)

Bellerophon Therapeutics Key Stats

EPS
According to the latest financial report of Bellerophon Therapeutics, the latest earnings per share (TTM) for the company is -0.16. Investing in companies with strong earnings per share can potentially provide higher returns.

Quarterly

Loading...

FCF
Interested in knowing about Bellerophon Therapeutics's free cash flow? The latest report shows it as -6.33M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Bellerophon Therapeutics shows that the company's current ratio is 3.96, indicating healthy liquidity.

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Bellerophon Therapeutics, the quick ratio is 3.49, indicating that the company can meet its short-term debt obligations.

Quarterly

Loading...

ROE
Want to learn more about the financial health of Bellerophon Therapeutics? The latest ROE figure is -41.11%, indicating that the company has stable profitability.

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Bellerophon Therapeutics, the total asset return on investment (ROA) is -23.68%.

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Bellerophon Therapeutics's latest financial report to see how their gross margin is doing - currently at --.

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Bellerophon Therapeutics, the net profit margin is 50.04%, which is a good sign for its profitability.

Quarterly

Loading...

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg